NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM5276937 Query DataSets for GSM5276937
Status Public on Nov 04, 2021
Title Patient_5_366C5L_RNA
Sample type SRA
 
Source name Tumor of the endometrium
Organism Homo sapiens
Characteristics race_ethnicity: Caucasian
tissue: Tumor
tumor_site: Endometrium
histology: Endometrioid
metastatic status: Primary/Non-metastatic
patient: 5
Treatment protocol NA
Growth protocol NA
Extracted molecule total RNA
Extraction protocol Tumor specimens were minced using two razor blades and digested overnight in 20-30 mL DMEM/F12 + 5% FBS, 15mM HEPES (Gibco), 1x Glutamax (Gibco), 1x Collagenase/Hyaluronidase (Stem Cell Technologies), 1% Penicillin/Streptomycin (Corning), and 0.48 µg/mL Hydrocortisone (Stem Cell Technologies) on a stir plate at 37°C and 180 rpm. For ovarian tumors, Gentle Collagenase/Hyaluronidase (Stem Cell Technologies) was used instead of Collagenase/Hyaluronidase. After digestion, tumor cells were washed twice with cold PBS + 2% FBS and 10mM HEPES (PBS-HF) and centrifuged at 1200 rpm for 5 min at room temperature. To remove red blood cells, the cell pellet was treated with 4 or 8 mL cold Ammonium Chloride Solution (Stem Cell Technologies) with 1 or 2 mL PBS-HF, respectively, for 1 minute, then centrifuged at 1200 rpm for 5 min. The amount of Ammonium Chloride Solution added was based on the size of the cell pellet and visual assessment of pink or red color present in the pellet. This step was repeated a second time if the pellet still exhibited a pink or red color after initial treatment. To further dissociate the cells, pellets were resuspended in 1-2 mL 0.05% Trypsin-EDTA (Gibco) and the suspension was gently pipetted up and down for 1 min. After 1 min, trypsin was inactivated by adding 10mL PBS-HF solution. The suspension was then centrifuged at 1200rpm for 5 min. If cell suspensions were clumpy, cells were resuspended with 1-2 mL Dispase (Stem Cell Technologies) and 200 µL 1mg/mL DNase I (Stem Cell Technologies) for 1 min, then inactivated with 10 mL PBS-HF. If the Dispase step was not necessary, cells were treated with DNase I during the trypsinization step. Cells were again centrifuged at 1200 rpm for 5 min, then washed in 10 mL PBS-HF and filtered through a 100µm cell strainer. A final centrifugation step was done at 1200 rpm for 5 min. The cell pellet was resuspended in DMEM/F12 + 5% FBS using a volume based on the final pellet size and filtered using a 40µm cell strainer. Single-cell suspension concentration and cell viability was measured by adding 10 µL 0.4% Trypan Blue to 10 µL cell suspension and measuring with the Countess II Automated Cell Counter (Thermo Fisher, AMQAX1000). We aimed for cell viability above 60% for the cells to be used for single-cell sequencing. Cell viability varied between 64% and 94% across all samples, with the majority of tumor suspensions being over 70% viable.
To continue with scRNA-seq, the cell suspension was diluted to 1200 cells/µL and 10,000 cells were used in library preparation using the 10x Genomics Chromium Single Cell 3’ GEM Kit v3 (PN-1000077) following the manufacturer’s protocol. To continue with scATAC-seq, 500,000 cells were used in nuclei isolation following the Nuclei Isolation for Single Cell ATAC Sequencing protocol from 10x Genomics. For the lysis step, cells were lysed for 4 min. For the resuspension step, nuclei were resuspended in 50 µL 1x Nuclei Buffer. Nuclei were counted by adding 10 µL 0.4% Trypan Blue to 10 µL nuclei suspension and counted with the Countess II Automated Cell Counter. 10,000 nuclei were then used in library preparation using the 10x Genomics Chromium Single Cell ATAC Library Kit v1 (PN-1000083) following the manufacturer’s protocol.
Libraries were sequenced on an Illumina NextSeq500 in the pair-end format using 10x Genomics recommended sequencing parameters.
 
Library strategy RNA-Seq
Library source transcriptomic
Library selection cDNA
Instrument model Illumina NextSeq 500
 
Description 366C5L_RNA
single-cell RNA-seq
Patient tumor tissue profiled by 10x scRNA-seq
Data processing scRNA-seq: The Cell Ranger Software Suite (version 3.1.0) was used for demultiplexing BCL files, alignment, barcode counting, and UMI counting for scRNA-seq libraries. GRCh38-3.0.0 was used as a reference transcriptome.
Specific details and instructions for running Cell Ranger can be found at: https://support.10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/what-is-cell-ranger
scATAC-seq: The Cell Ranger ATAC Software Suite (version 1.2.0) was used for demultiplexing BCL files, alignment, barcode counting, and generating fragments.tsv.gz files for scATAC-seq libraries. refdata-cellranger-atac-GRCh38-1.2.0 was used as a genomic reference.
Specific details and instructions for running Cell Ranger ATAC can be found at: https://support.10xgenomics.com/single-cell-atac/software/pipelines/latest/what-is-cell-ranger-atac
Genome_build: hg38 (GRCh38)
Supplementary_files_format_and_content: Cell Ranger scRNA filtered feature barcode matrices contain gene counts for cellular barcodes.
Supplementary_files_format_and_content: Cell Ranger scATAC fragments files list unique ATAC fragments per barcode sequence.
 
Submission date Apr 30, 2021
Last update date Nov 05, 2021
Contact name Hector L Franco
E-mail(s) hfranco@med.unc.edu
Organization name UNC Lineberger Cancer Center
Department Genetics
Lab Franco Lab
Street address 120 Mason Farm Rd
City Chapel Hill
State/province NC
ZIP/Postal code 27599-7265
Country USA
 
Platform ID GPL18573
Series (1)
GSE173682 A multi-omic single-cell atlas of human gynecological malignancies
Relations
BioSample SAMN17812862
SRA SRX10293532

Supplementary file Size Download File type/resource
GSM5276937_barcodes-366C5L.tsv.gz 35.3 Kb (ftp)(http) TSV
GSM5276937_features-366C5L.tsv.gz 297.6 Kb (ftp)(http) TSV
GSM5276937_matrix-366C5L.mtx.gz 55.1 Mb (ftp)(http) MTX
SRA Run SelectorHelp
Processed data provided as supplementary file
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap